Most Recent
Costly IP cases could make Australian courts look bad, Dynastat patent judge says
A judge overseeing patent litigation over the painkiller Dynastat has urged the parties to narrow any issues in dispute, saying the excessive amounts of money spent in these types of cases could harm public perception.
Ex-boss of medical tech firm Respiri sues over termination
The former CEO of Respiri has levelled a slew of claims at the ASX-listed medical technology company and two of its former directors, including breach of the Fair Work Act, as well as failure to pay short term incentives (STI) and vest options valued at $2.2 million.
Lawyer wins $750,000 in defamation case over negative Google reviews
An Adelaide lawyer has been awarded $750,000 in damages after suing a woman who gave him bad reviews on Google that sent 80 per cent of his clients packing.
Biotechs to battle in Federal Court over ‘Access’ trade marks
Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company's 'Access' trade mark is likely to confuse consumers.
Judge tosses Vagisil maker’s challenge to European rival’s trade mark
The international company behind the Vagisil feminine hygiene brand has lost its bid to stop a European competitor from registering Vagisan as a trade mark in Australia.
FWC dismisses case after Facebook pics show ‘agoraphobic’ beautician sunning it up
The Fair Work Commission has dismissed a general protections dispute brought by an "agoraphobic" beautician after social media posts revealed an active social life including gin, Greek food and the Melbourne Cup.
Bupa takes regulator to court as it fights ACCC allegations it overcharged, misled residents
Bupa has launched court action to block a directive by the Aged Care Quality and Safety Commission as the aged care provider battles a separate case by the ACCC over payments allegedly charged to residents for services they did not receive.
Biosimilar drug makers settle IP spat over arthritis drug Humira
German drug company Fresenius Kadi has resolved a patent case brought by Korean drug company Samsung Bioepis over a biosimilar of top selling arthritis drug Humira.
ATO appeals ruling in $60M dispute with Healius over lump sum payments
The Australian Taxation Office has appealed a Federal Court judgment that healthcare company Healius could recover a tax refund and associated interest estimated to be worth about $60 million.
Trial date vacated again in Country Care criminal cartel case
A judge has vacated an upcoming trial date in a criminal cartel proceeding against mobile equipment provider Country Care Group and two individuals, and allowed the defendants to appeal a first-of-its-kind ruling on jury directions in criminal cartel cases.